Latest Schedule 13D activist filings

Yunqi Capital and affiliates reiterate their intention to vote against STAAR Surgical's proposed merger, citing concerns over recent disclosures and urging a special stockholder meeting.

R01 Fund LP and its affiliates increased their beneficial ownership in NovaBay Pharmaceuticals, Inc. to 45.1% through the conversion of Series D preferred stock and the acquisition of new Series E preferred stock.

Framework Ventures IV L.P. and its affiliates have increased their beneficial ownership in NovaBay Pharmaceuticals, Inc. to 45.1% through convertible preferred stock and a pre-funded warrant.

Atlas Venture entities have reduced their collective beneficial ownership in Sionna Therapeutics, Inc. to 7.0% through recent share sales.

Saba Capital Management and affiliates have increased their beneficial ownership in The Gabelli Healthcare & WellnessRx Trust to 13.3%.

Skycrest Holdings, LLC has increased its beneficial ownership in Zeo Scientifix, Inc. to 7.04% through recent open market purchases.

Star Equity Fund, LP and Gyrodyne, LLC have entered into a settlement agreement, leading to the withdrawal of Star Equity's director nominations and changes to Gyrodyne's board structure and governance.

Nvni Group Limited's CEO, Pierre Schurmann, increased his beneficial ownership to 15.84% of ordinary shares through recent acquisitions.

A group of major shareholders, including Manfredi Lefebvre d'Ovidio, reduced their beneficial ownership in Arqit Quantum Inc. to 43.2% following recent sales of shares and warrants.

A major shareholder of H World Group Limited, East Leader International Limited, has revoked a long-standing power of attorney granted to Mr. Qi Ji, effective October 20, 2025.

H World Group Limited's Schedule 13D/A filing details updated beneficial ownership for Qi Ji and Winner Crown Holdings, alongside the revocation of a power of attorney granted to Qi Ji by East Leader International Limited.

Apeiron Investment Group and related entities increased their beneficial ownership in ATAI Life Sciences N.V. to 24.0% following a share conversion and a new lock-up agreement.

Blue Owl Capital Holdings LP increased its beneficial ownership in Katapult Holdings, Inc. to 42.74% due to an increase in conversion shares driven by the issuer's stock price.

RA Capital Management and its affiliates reported a reduction in their beneficial ownership of VOR BioPharma Inc. common stock to 20.9% through recent open market sales.

Bakkt Holdings, Inc. announced a corporate reorganization to eliminate its Up-C structure, becoming a subsidiary of a new public holding company, accompanied by amendments to its Tax Receivable Agreement and related agreements with Intercontinental Exchange Holdings, Inc. and CEO Akshay Naheta.

Bakkt Holdings, Inc. announced a corporate reorganization to eliminate its Up-C structure, becoming a subsidiary of a new public holding company, accompanied by amendments to its Tax Receivable Agreement and related agreements with Intercontinental Exchange Holdings, Inc. and CEO Akshay Naheta.

Konstantinos Konstantakopoulos and affiliated entities increased their beneficial ownership in Costamare Bulkers Holdings Ltd. to 30.9% through recent share acquisitions and service agreements.

Green Thumb Industries affiliates, including RSLGH, LLC, have increased their beneficial ownership in RYTHM, Inc. to 49.99% through various equity instruments and warrant issuances.

Sit Investment Associates and Sit Fixed Income Advisors II have disclosed a 5.6% beneficial ownership stake in Eaton Vance Limited Duration Income Fund, acquired for investment purposes.

Sit Investment Associates and Sit Fixed Income Advisors II have disclosed a 6.4% beneficial ownership in Eaton Vance Short Duration Diversified Income Fund, signaling potential engagement with management.

A group of investors, holding 15.8% of CollPlant Biotechnologies, is advocating for immediate changes to the company's Board of Directors, including a new Chairman.

Activist investor Impactive Capital, holding a 6.4% stake in WEX Inc., announced its intention to nominate a slate of directors for the 2026 Annual Meeting, citing persistent underperformance and governance concerns.

Individual investor Mark Andrew Uram has increased his beneficial ownership in Crypto Co to 14.1% of outstanding common stock, acquiring 674 million shares with personal funds.

Mark Andrew Uram has increased his beneficial ownership in Crypto Co to 14.1% of outstanding common stock, holding 674 million shares for investment purposes.

Michael Anthony Belfiore has acquired a 22.1% beneficial ownership stake in AIRWA INC. for investment purposes, signaling potential engagement on corporate governance and strategy.

Casdin Capital and its affiliates have increased their beneficial ownership in BioLife Solutions, Inc. to 12.4% through a recent share acquisition.

Reprogrammed Interchange LLC and Reid Hoffman significantly reduced their beneficial ownership in Vor Biopharma Inc. through open market sales.

Rubric Capital Management LP and David Rosen increased their beneficial ownership in Heron Therapeutics, Inc. to 15.9% following the conversion of preferred stock and a convertible note issuance.

Gilde Healthcare has significantly reduced its beneficial ownership in LAVA Therapeutics N.V. by selling over 2.2 million common shares in open market transactions.

David E. Lazar, NovaBay Pharmaceuticals' CEO and director, has sold a significant portion of his preferred stock and rights to new investors, resigning from his roles.